Cambridge Cognition (COG) Hits New 1-Year Low at $66.00

Cambridge Cognition Holdings PLC (LON:COG)’s share price hit a new 52-week low during mid-day trading on Monday . The company traded as low as GBX 66 ($0.86) and last traded at GBX 69 ($0.90), with a volume of 18665 shares traded. The stock had previously closed at GBX 70.50 ($0.92).

Separately, FinnCap reiterated a “corporate” rating on shares of Cambridge Cognition in a report on Tuesday, March 19th.

The company has a market cap of $16.61 million and a price-to-earnings ratio of -9.86.

ILLEGAL ACTIVITY NOTICE: “Cambridge Cognition (COG) Hits New 1-Year Low at $66.00” was published by Community Financial News and is owned by of Community Financial News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The legal version of this story can be accessed at

About Cambridge Cognition (LON:COG)

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops digital health products. The company offers CANTAB Recruit, an online patient recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from phases I–IV or a cognitive testing software that enhances the chances of success and minimizing the risk of failure in neuroscience research; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication.

Recommended Story: What is Compound Interest?

Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with's FREE daily email newsletter.


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit